Joseph Elijah, Northeastern University

Joseph Elijah

PharmD, BCPS

Assistant Clinical Professor

Pharmacy and Health Systems Science


Research Interests

Real-world safety and efficacy outcomes of oncologic therapies for solid tumor malignancies, immunotherapy, oral oncolytics/targeted therapies

Overview

Joseph Elijah holds a Doctor of Pharmacy degree with Highest Distinction from the University of Michigan College of Pharmacy and a Bachelor of Science in Biological Sciences degree, graduating Summa Cum Laude from Oakland University. Dr. Elijah’s pursuit of advanced clinical and academic training continued through his completion of two comprehensive pharmacy residencies.

He successfully completed a PGY1 Pharmacy Practice Residency at the University of Michigan Health System, followed by a PGY2 Hematology/Oncology Pharmacy Residency at the Roswell Park Comprehensive Cancer Center in Buffalo, New York. Dr. Elijah’s research interests are centered around innovative approaches to oncology care. His dedication to improving patient outcomes is reflected in his focus on solid tumor oncology, immunotherapy, and oral oncolytic agents.

Dr. Elijah’s work aims to bridge the gap between clinical practice and research, as he utilizes his dual roles as an ambulatory clinical oncology pharmacist at Massachusetts General Hospital and a faculty member to explore unanswered clinical questions in the dynamic field of oncology. 

Selected Publications

Elijah J, Fitzgerald L, Phan H. Use of CFTR Modulators in Special Populations, Part 2: Severe Lung Disease. Pediatric Pulmonology. Pediatr Pulmonol. 2023;10.1002/ppul.26698

Kadouh N, Elijah J, Fitzgerald L, Phan H. Use of CFTR Modulators in Special Populations, Part 3: Solid Organ Transplant. Pediatric Pulmonology. Pediatr Pulmonol. 2023;10.1002/ppul.26396

Elijah J, Jain P, Holdsworth A, Baron J, Przespolewski E, Attwood K, Wang K, Billias C, Dy G. Real World Outcomes of Trilaciclib in ES-SCLC. J Clin Oncol 41. 2023 (suppl 16; abstr e20637)

Elijah J, Schepers A, Krauss J, McDevitt R. Risk Factors for Biliary Toxicity in Patients with Implanted Hepatic Artery Infusion Pumps. J Oncol Pharm Pract. 2023;10781552231158744Elijah J, Powell K, Smith M. The Efficacy of Capsaicin on Sleep Quality and Fatigue in Fibromyalgia: A Systematic Review. J Pain Palliat Care Pharmacother. 2022; 36(2): 112-116.

Selected Public Service

Reviewer for the Journal of Pain and Palliative Care Pharmacotherapy

Classes Taught

Comprehensive Disease Management 4
Oncology Pharmacy Elective
Integrated Science and Therapeutics 3
Integrated Science and Therapeutics 7